antisense oligonucleotides (Gilead)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameantisense oligonucleotides (Gilead)
Drug Alias Nameantisense oligonucleotide (Glaxo)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionVirus replication inhibitorsAntisense oligonucleotide inhibitorsNucleic acid metabolism modulators
TargetsUpdating
Therapy Area/IndicationsFlavivirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGilead Sciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGilead Sciences IncGlaxo Group Ltd
Active IndicationsN/A
Inactive IndicationsFlavivirus Infections

Other Information

ATC CodeN/A
Related LinksN/A